Giuseppe is a co-founder and Partner at Medicxi. Prior to Medicxi, Giuseppe co-founded Index Ventures in 1996. He co-led the team that launched Index’s first growth fund in 2007 and, in 2016, had a leading role in the launch of Medicxi’s first growth fund. Giuseppe currently serves on the board of a number of Index and Medicxi portfolio companies, including Levicept.
Giuseppe’s prior investments include Micromet Inc. (acquired by Amgen) and Ariad (NASDAQ: ARIA, acquired by Takeda).
Prior to co-founding Index, Giuseppe spent five years as a consultant with McKinsey.
Giuseppe received a BA in Corporate Finance from the Bocconi University in Milan and an MBA from the Stanford Graduate School of Business. Giuseppe serves on the Board of Directors of the Stanford Alumni Association, Stanford University.